Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
05/2009
05/26/2009US7538215 Compounds which inhibit leukocyte adhesion mediated by VLA-4
05/26/2009US7538214 2-(poly-substituted aryl)-6-amino-5-halo-4-pyrimidinecarboxylic acids and their use as herbicides
05/26/2009US7538115 Substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
05/26/2009US7538104 Photoactivable nitrogen bases
05/26/2009US7538072 Using an acylurea compound containing pyrimidine ring;; used before the harvest of crops such as potato, sunflower, soybean, rape, sorghum and the like; methyl [2-{2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-1,2,3,6-tetrahydropyrimidin-1-yl]phenoxy}phenoxy]acetate
05/26/2009CA2474373C N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substituent on the methyl useful as bradykinin antagonists
05/26/2009CA2434843C Novel couplers for use in oxidative hair dyeing
05/26/2009CA2344058C Diaminopropionic acid derivatives
05/22/2009WO2009064449A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
05/22/2009WO2009063054A1 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases
05/22/2009WO2009062402A1 Quinazolinone derivatives, the preparation methods and uses thereof
05/22/2009WO2009023299A3 Anti-angiogenic agents and methods of use
05/22/2009CA2705922A1 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases
05/22/2009CA2703220A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
05/21/2009US20090131665 Process for the preparation of crystalline forms A, B and pure crystalline form a of erlotinib HCI
05/21/2009US20090131463 Novel compounds
05/21/2009US20090131461 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity
05/21/2009US20090131456 Caspase inhibitors and uses thereof
05/21/2009US20090131436 Pyrimidine Derivatives
05/21/2009US20090131435 Heterocyclic inhibitors of mek and methods of use
05/21/2009US20090131384 Compounds and methods for treatment of disorders associated with er stress
05/21/2009US20090130487 Compounds for placing objects by self assembling and the use thereof
05/21/2009US20090130097 Quinazolinone Compounds and Methods of Use Thereof
05/20/2009EP2060565A1 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases
05/20/2009EP2059511A1 Sulphoximides as protein kinase inhibitors
05/20/2009EP2059507A2 Ep2 agonists
05/20/2009EP1301489B1 Synthesis of chlorinated pyrimidines
05/20/2009CN101438288A Regulation of phosphoryl transferase activity of glutamine synthetase
05/20/2009CN101437800A Compounds and compositions as HEDGEHOG pathway modulators
05/20/2009CN101437778A Reaction reagent for trifluoromethylation
05/20/2009CN101434585A Amide derivatives as GK activators
05/20/2009CN100488958C 3-substituted-4-pyrimidone derivatives
05/20/2009CN100488952C 5-phenyl pyridine, its preparation method and intermediate product and uses in controlling harmful fungus
05/19/2009US7534798 Vanilloid receptor ligands and their use in treatments
05/19/2009CA2468879C Substituted cyclohexane derivatives
05/19/2009CA2368059C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
05/14/2009WO2009062087A1 Processes for the preparation of uracil derivatives
05/14/2009WO2009062036A2 Processes for preparing levocetirizine and pharmaceutically acceptable salts thereof
05/14/2009WO2009061879A1 Peptide deformylase inhibitors
05/14/2009WO2009061498A1 CYCLIC UREA INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1
05/14/2009WO2009060835A1 Novel ubiquilin-binding small molecule
05/14/2009WO2009060209A1 6,6-fused bicyclic aromatic compounds and their therapeuti use
05/14/2009WO2009059783A1 Stereo-specific hydroxylation
05/14/2009WO2008118823A3 Compositions and methods for inhibition of the jak pathway
05/14/2009WO2008049123A8 2,4-pyrimidinediamine derivatives as inhibitors of jak kinases for the treatment of autoimmune diseases
05/14/2009WO2006012624A3 Mechanism-based crosslinkers
05/14/2009US20090124803 Process for preparation of rosuvastatin
05/14/2009US20090124796 Nucleobase Having Perfluoroalkyl Group and Process for Producing the Same
05/14/2009US20090124645 Novel Pyrimidine-2,4-Diamine Derivatives and their Use as Modulators of Small-Conductance Calcium-Activated Potassium Channels
05/14/2009US20090124644 Hiv inhibiting 2-(4-cyanophenylamino) pyrimidine derivatives
05/14/2009US20090124642 Crystalline forms of Erlotinib HCI and formulations thereof
05/14/2009US20090124641 Mitotic Kinesin Inhibitors
05/14/2009US20090124636 Chemical compounds
05/14/2009US20090124625 Novel alkynyl derivatives as modulators of metatropic glutamate receptors
05/14/2009US20090124607 Novel Bicyclic Sulfonamides for Use as Glucocorticoid Receptor Modulators in the Treatment of Inflammatory Diseases
05/14/2009US20090124604 4-oxoquinazolin-3-yl benzamide derivatives for the treatment of cytokine diseases
05/14/2009CA2705246A1 Peptide deformylase inhibitors
05/14/2009CA2704222A1 Cyclic urea inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
05/13/2009EP2057140A1 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders
05/13/2009EP2057129A1 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders
05/13/2009EP2057121A2 Insecticidal n-substituted (heteroaryl)alkyl sulfilimines
05/13/2009EP1587795B1 N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1-piperidincarboxamid-derivatives and related compounds use as cgrp-antagonists for treating a headache
05/13/2009EP1466174B1 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
05/13/2009EP1305026B1 Barbituric acid analogs as therapeutic agents
05/13/2009EP1062209B1 Metabolically inert anti-inflammatory and anti-tumor antifolates
05/13/2009CN101429166A Quinazoline ketone derivant, preparation method and application thereof
05/13/2009CN101429165A Synthesis of quinazoline ketone compounds
05/13/2009CN101429164A Levorotation benzhydryl piperazidine derivant and preparing method thereof
05/12/2009US7531654 Process for producing substituted aniline compound
05/12/2009US7531577 3-Fluoro-N-(5-ureidomethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-benzenesulfonamide; serotonin receptors 5-HT6 and 5-HT2A ligand; neurodegenerative disorders; antidepressant, anxiolytic agent; Parkinson's disease, Huntington's disease, manic depression, psychoses, epilepsy, obesity, drug abuse
05/12/2009US7531548 to inhibit the replication of mutant strains, in particular strains which are resistant to NNRTI drugs (Non Nucleoside Reverse Transcriptase Inhibitor drugs); to treat HIV infections
05/12/2009US7531547 Diaminopyrimidines as P2X3 and P2X2/3 modulators
05/12/2009US7531541 Metabotropic glutamate receptor antagonists; phenylethynylpyrimidines and phenylethynylpyrazines; treating anxiety, epilepsy, schizophrenia, other psychotic disorder, Parkinson's disease, or addictive disorder
05/12/2009US7531538 α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
05/12/2009US7531532 Pyridine derivative and pyrimidine derivative
05/12/2009CA2361402C Bis-sulfonamides
05/12/2009CA2278553C Phenylsulfonylureas, processes for their preparation, and their use as herbicides and plant growth regulators
05/07/2009WO2009058348A1 Amide derivatives as sirtuin modulators
05/07/2009WO2009057139A2 Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents
05/07/2009US20090118507 Method for Preparing (3-Chloro-4-Fluorophenyl)-(4-Fluoro-4--Piperidin-1-Yl)-Methanone and Novel Intermediate Pyrimidine Derivatives
05/07/2009US20090118505 Process for the preparation of substituted phenylalanines
05/07/2009US20090118314 Tumor suppressor
05/07/2009US20090118313 Treating atherosclerosis by administering 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one or a salt; coadministering an antioxidant probucol; inhibitor of platlet activating factor acetylhydrolase
05/07/2009US20090118311 DHFR Enzyme Inhibitors
05/07/2009US20090118308 2,2-Bis-(hydroxymethyl)cyclopropylidenemethyl-Purines and -Pyrimidines As Antiviral Agents
05/07/2009US20090118307 Aryl Sulfonamides
05/07/2009US20090118283 Amide Derivatives as Kinase Inhibitors
05/07/2009US20090118261 Quinazolinone derivatives and their use as b-raf inhibitors
05/07/2009US20090118224 Agent against psychosocial stresses
05/07/2009US20090117040 Novel pharmaceutical and diagnostic compositions for use in the treatment and diagnosis of neurodegenerative diseases or amyloid diseases
05/07/2009CA2704336A1 Amide derivatives as sirtuin modulators
05/07/2009CA2703909A1 P2x3, receptor antagonists for treatment of pain
05/07/2009CA2703767A1 Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents
05/06/2009EP2055697A1 Design and synthesis of novel tubulin polymerization inhibitors: benzoylphenylurea (BPU) sulfur analogs
05/06/2009EP2054393A1 Crystalline erlotinib
05/06/2009EP2054392A2 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase c-alpha
05/06/2009EP2054391A1 Crystalline moxonidine comprising single tautomer and preparation process therefor
05/06/2009EP2054063A2 4-aminoquinazoline derivatives and methods of use thereof
05/06/2009EP1343782B1 Pyrimidineamines as angiogenesis modulators
05/06/2009EP1272193B1 Synergistic combination therapy for treating cancer